Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2135
-0.0180 (-7.78%)
Mar 28, 2025, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 327.12 million as of March 28, 2025. Its market cap has increased by 673.87% in one year.
Market Cap
327.12M
Enterprise Value
394.51M
Revenue
198.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 327.12M, an increase of 149.61%. That is a compound annual growth rate of 10.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 100.22B |
| Getinge AB | 60.30B |
| Sectra AB | 47.64B |
| Camurus AB | 34.16B |
| Medicover AB | 29.07B |
| Vitrolife AB | 22.43B |
| Vimian Group AB | 21.69B |
| Elekta AB | 20.63B |